GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center today announced the successful implantation of an AVEIR™ DR pacemaker system, becoming the first hospital in Northern California to insert the world’s first dual chamber leadless pacemaker system. The groundbreaking system, approved by the U.S.

加利福尼亚州格林布雷（商业新闻短讯）--MarinHealth医疗中心今天宣布成功植入AVEIR™DR起搏器系统，成为加利福尼亚州北部第一家插入世界上第一个双腔无铅起搏器系统的医院。美国批准的开创性系统。

Food and Drug Administration (FDA) in June 2023, provides MarinHealth physicians with a new and minimally invasive option to treat the nearly 80% of pacemaker recipients who require pacing of the heart in two chambers of the heart (both the right atrium and right ventricle)..

2023年6月，美国食品和药物管理局（FDA）为MarinHealth医生提供了一种新的微创选择，用于治疗近80%需要在两个心室（右心房和右心室）起搏心脏的起搏器接受者。。

“MarinHealth is proud to be at the forefront in the clinical care of heart rhythm disorders. For example, in the field of atrial fibrillation, we recently completed clinical trials of pulsed field ablation, providing our patients with proficient treatment with the newest ablation technology. For the prevention of strokes related to atrial fibrillation, we remain home to the largest percutaneous left atrial appendage occlusion program in the Bay Area.

“MarinHealth很自豪能够在心律失常的临床护理方面走在前列。例如，在心房颤动领域，我们最近完成了脉冲场消融的临床试验，为我们的患者提供了最新的消融技术的熟练治疗。为了预防与房颤相关的中风，我们仍然是湾区最大的经皮左心耳闭塞项目的所在地。

Now, we are excited to become the first center in Northern California to offer dual chamber leadless pacemaker technology, which provides yet another state-of-the-art solution for heart rhythm patients in our community,” said Anita Chandrasena, MD, Chief Medical Officer of MarinHealth..

现在，我们很高兴成为北加利福尼亚州第一个提供双腔无铅起搏器技术的中心，该技术为我们社区的心律患者提供了另一种最先进的解决方案，”MarinHealth首席医疗官Anita Chandrasena医学博士说。。

Unlike traditional pacemakers, leadless devices are small capsules that entirely reside within the heart chamber and are implanted with a needle inserted in the leg via a tube roughly the size of a drinking straw. Roughly one-tenth the size of a traditional pacemaker, the dual chamber AVEIR leadless pacing system is made up of two devices: a ventricular (VR) and an atrial (AR) leadless pacemaker.

与传统的起搏器不同，无铅装置是一种小胶囊，完全位于心脏腔内，并通过大约一根吸管大小的管子将针头插入腿部。双腔AVEIR无铅起搏系统大约是传统起搏器的十分之一，由两个装置组成：心室（VR）和心房（AR）无铅起搏器。

The system incorporates a novel implant-to-implant or “i2i” technology, which solves the significant engineering challenge of communication between the two devices. The i2i system sends high-frequency pulses to relay messages via the blood pool's naturally conductive characteristics, dramatically reducing energy requirements compared to existing technologies and extending device battery life..

该系统采用了一种新型的植入物对植入物或“i2i”技术，解决了两个设备之间通信的重大工程挑战。i2i系统通过血池的自然导电特性发送高频脉冲以中继信息，与现有技术相比，大大降低了能量需求，延长了设备电池寿命。。

“Leadless pacemaker technology, especially with dual chamber capability, is the most exciting recent advance in the pacemaker field,” said Vivek Iyer, MD, Director of the Cardiac Electrophysiology program at MarinHealth, who successfully performed the procedure. “Traditional pacing leads are well-constructed, but they can fail.

MarinHealth心脏电生理项目主任Vivek Iyer医学博士说：“无铅起搏器技术，特别是具有双腔功能的起搏器技术，是起搏器领域最令人兴奋的最新进展。”。“传统的起搏导线构造良好，但可能会失败。

Consider that the metal wire inside the traditional lead flexes with each heartbeat about 100,000 times a day. Though oversimplified, that’s like repeatedly bending a very resilient paper clip. Though problems occur in a small percent of patients, physically active and younger patients are particularly at risk of that internal wire fracturing at some point in their lifetime.”.

试想一下，传统导线内部的金属线每天每跳动约10万次就会弯曲。虽然过于简化，但这就像反复弯曲一个非常有弹性的回形针。尽管只有一小部分患者会出现问题，但体力活动和年轻患者在其一生中的某个时候尤其容易出现内部钢丝断裂的风险。”。

“Furthermore, since this procedure, amazingly, requires no skin incision or pocket to place a battery in the shoulder area, healing can also be smoother,” Dr. Iyer added. “So older patients, and those at risk of infection, such as dialysis patients or those on immunosuppression, also benefit from leadless pacemakers.

“此外，令人惊讶的是，由于这种手术不需要皮肤切口或口袋就可以在肩部区域放置电池，因此愈合也可以更顺利，”Iyer博士补充道。“因此，老年患者和有感染风险的患者，如透析患者或免疫抑制患者，也受益于无铅起搏器。

We are excited about where this technology is and where it might take us.”.

我们对这项技术的现状以及它可能带给我们的前景感到兴奋。”。

If you or someone you know wish to learn more about pacemakers or leadless pacemaker technology, talk to a doctor at the Haynes Cardiovascular Institute to see your treatment options. Visit https://www.mymarinhealth.org/programs-services/cardiovascular-medicine/electrophysiology/.

如果你或你认识的人想更多地了解起搏器或无铅起搏器技术，请与海恩斯心血管研究所的医生交谈，看看你的治疗选择。访问https://www.mymarinhealth.org/programs-services/cardiovascular-medicine/electrophysiology/.

About MarinHealth

关于MarinHealth

MarinHealth is an integrated healthcare enterprise with deep roots in the North Bay. With a world-class physician and clinical team, an ever-expanding network of clinics, and a new state-of-the-art hospital, MarinHealth stops at nothing to help patients achieve their best health. MarinHealth is comprised of MarinHealth Medical Center, a 327-bed hospital located in the heart of Marin since 1952, the MarinHealth Medical Network with 55+ primary care and specialty clinics located in Marin, Sonoma, and Napa counties, and the MarinHealth Foundation, an organization whose mission is to inspire philanthropy for the benefit of MarinHealth.

MarinHealth是一家综合性医疗保健企业，在北湾有着深厚的根基。MarinHealth拥有世界一流的医生和临床团队，不断扩大的诊所网络，以及一家新的最先进的医院，它不遗余力地帮助患者实现最佳健康。MarinHealth由MarinHealth医疗中心（MarinHealth Medical Center）和MarinHealth基金会（MarinHealth Foundation）组成，MarinHealth医疗中心自1952年以来一直位于马林市中心，拥有327张病床，MarinHealth医疗网（MarinHealth Medical Network）在马林（Marin）、索诺马（Sonoma）和纳帕（Napa）县拥有55多家初级保健和专科诊所，MarinHealth基金会（Mari。

A long-term partnership with UCSF expands MarinHealth’s world-class capabilities and its portfolio of services to serve more of our North Bay community in new and better ways. For more information, visit MyMarinHealth.org..

与UCSF的长期合作扩大了MarinHealth的世界级能力及其服务组合，以新的更好的方式为我们北湾社区的更多人服务。有关更多信息，请访问MyMarinHealth.org。。

For important U.S. safety information on AVEIR™ DR, visit https://www.cardiovascular.abbott/us/en/customer-service.html.

有关AVEIR™DR的重要美国安全信息，请访问https://www.cardiovascular.abbott/us/en/customer-service.html.